Literature DB >> 33930298

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.

Wilfredo F Garcia-Beltran, Evan C Lam, Kerri St Denis, Adam D Nitido, Zeidy H Garcia, Blake M Hauser, Jared Feldman, Maia N Pavlovic, David J Gregory, Mark C Poznansky, Alex Sigal, Aaron G Schmidt, A John Iafrate, Vivek Naranbhai, Alejandro B Balazs.   

Abstract

Entities:  

Year:  2021        PMID： 33930298      PMCID： PMC8082941          DOI： 10.1016/j.cell.2021.04.006

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
(Cell 184, 2372–2383.e1–e9; April 29, 2021) Due to a production error, the received date for this article was originally published as February 12, 2020, but the correct date is February 12, 2021. This error has been corrected online and in the print version. The journal apologizes for any confusion.
  102 in total

1.  InterARTIC: an interactive web application for whole-genome nanopore sequencing analysis of SARS-CoV-2 and other viruses.

Authors:  James M Ferguson; Hasindu Gamaarachchi; Thanh Nguyen; Alyne Gollon; Stephanie Tong; Chiara Aquilina-Reid; Rachel Bowen-James; Ira W Deveson
Journal:  Bioinformatics       Date:  2021-12-15       Impact factor: 6.937

2.  SARS-CoV-2 variants and vaccination.

Authors:  Yang Liu; Jianying Liu; Pei-Yong Shi
Journal:  Zoonoses (Burlingt)       Date:  2022-02-08

3.  Mutation-Specific SARS-CoV-2 PCR Screen: Rapid and Accurate Detection of Variants of Concern and the Identification of a Newly Emerging Variant with Spike L452R Mutation.

Authors:  Huanyu Wang; Sophonie Jean; Richard Eltringham; John Madison; Pamela Snyder; Huolin Tu; Daniel M Jones; Amy L Leber
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

4.  The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant.

Authors:  David Hodgson; Stefan Flasche; Mark Jit; Adam J Kucharski
Journal:  Euro Surveill       Date:  2021-05

5.  Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β.

Authors:  Donald C Vinh; Laurent Abel; Paul Bastard; Matthew P Cheng; Antonio Condino-Neto; Peter K Gregersen; Filomeen Haerynck; Maria-Pia Cicalese; David Hagin; Pere Soler-Palacín; Anna M Planas; Aurora Pujol; Luigi D Notarangelo; Qian Zhang; Helen C Su; Jean-Laurent Casanova; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2021-06-08       Impact factor: 8.542

Review 6.  SARS-CoV-2 variants, spike mutations and immune escape.

Authors:  William T Harvey; Alessandro M Carabelli; Ben Jackson; Ravindra K Gupta; Emma C Thomson; Ewan M Harrison; Catherine Ludden; Richard Reeve; Andrew Rambaut; Sharon J Peacock; David L Robertson
Journal:  Nat Rev Microbiol       Date:  2021-06-01       Impact factor: 78.297

7.  Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.

Authors:  Anusha Nathan; Elizabeth J Rossin; Clarety Kaseke; Ryan J Park; Ashok Khatri; Dylan Koundakjian; Jonathan M Urbach; Nishant K Singh; Arman Bashirova; Rhoda Tano-Menka; Fernando Senjobe; Michael T Waring; Alicja Piechocka-Trocha; Wilfredo F Garcia-Beltran; A John Iafrate; Vivek Naranbhai; Mary Carrington; Bruce D Walker; Gaurav D Gaiha
Journal:  Cell       Date:  2021-06-30       Impact factor: 66.850

Review 8.  SARS-CoV-2 one year on: evidence for ongoing viral adaptation.

Authors:  Thomas P Peacock; Rebekah Penrice-Randal; Julian A Hiscox; Wendy S Barclay
Journal:  J Gen Virol       Date:  2021-04       Impact factor: 3.891

9.  Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents.

Authors:  David H Canaday; Lenore Carias; Oladayo A Oyebanji; Debbie Keresztesy; Dennis Wilk; Michael Payne; Htin Aung; Kerri St Denis; Evan C Lam; Christopher F Rowley; Sarah D Berry; Cheryl M Cameron; Mark J Cameron; Brigid Wilson; Alejandro B Balazs; Stefan Gravenstein; Christopher L King
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

10.  2020 SARS-CoV-2 diversification in the United States: Establishing a pre-vaccination baseline.

Authors:  Adam A Capoferri; Wei Shao; Jon Spindler; John M Coffin; Jason W Rausch; Mary F Kearney
Journal:  medRxiv       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.